Hjem › Kræft (alle typer) › Washington
Kræft (alle typer) kliniske forsøg i Washington
58 studier for Kræft (alle typer) søger deltagere på steder i Washington.
Byer i Washington
- Seattle49 studier
- Tacoma6 studier
- Spokane6 studier
- Spokane Valley4 studier
- Vancouver3 studier
- Kirkland3 studier
Officiel studietekst (engelsk)
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Fred Hutchinson Cancer Center. /ID# 277939, Seattle
- Northwest Cancer Specialists - Vancouver /ID# 277855, Vancouver
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07155187Registry Study for Radiation Therapy Outcomes
- University of Washington, Seattle
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 29. sep. 2026 · NCT01255748A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Vista Oncology Inc PS, Olympia
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 25. sep. 2026 · NCT05920356Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Fred Hutchinson Cancer Center, Seattle
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04981119A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06989437A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Swedish Cancer Institute, Seattle
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06150157A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
- Seattle Children's Hospital, Seattle
Rekrutterer
Alder 15 til 24 · Alle køn · Opdateret 24. sep. 2026 · NCT07223463Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- Fred Hutchinson Cancer Center ( Site 0106), Seattle
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07405164A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Valley Medical Center /ID# 253950, Renton
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT04928846TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Northwest Medical Specialties, Bonney Lake
- Northwest Medical Specialties, Federal Way
- Northwest Medical Specialties, Gig Harbor
- og 4 flere
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 2/3
Alle aldre · Alle køn · Opdateret 18. sep. 2026 · NCT03435796Collection of Tissue Samples for Cancer Research
- Fred Hutchinson, Seattle
RekruttererObservationsstudie
2 Months · Alle køn · Opdateret 16. sep. 2026 · NCT00900198RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Seattle Neuropsychiatric Treatment Center, Seattle
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07002034A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT06953960Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 400, Seattle
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 10. sep. 2026 · NCT05997615A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06253871A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Swedish Cancer Institute - Edmonds, Edmonds
- Kadlec Clinic Hematology and Oncology, Kennewick
- Swedish Medical Center, Seattle
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Cancer Care Northwest, Spokane
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07169851A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- University of Washington, Seattle
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06163534Prostate Active Surveillance Study
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
RekruttererObservationsstudie
Alder 21 og opefter · Mænd · Opdateret 2. sep. 2026 · NCT00756665Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Cancer Care Northwest-1 (601 S. Sherman), Spokane
- Cancer Care Northwest_2 (605 E. Holland), Spokane
- Cancer Care Northwest, Spokane Valley
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06072612A Study of ARC-02 in B-cell NHL
- Summit Cancer Centers - North Spokane, Spokane
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT07691606Project: Every Child for Younger Patients With Cancer
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- og 1 flere
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT04104776Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT04515810A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 10. aug. 2026 · NCT06067841A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Seattle Children's Hospital Research Foundation, Seattle
RekruttererFase 2
Alder 1 til 39 · Alle køn · Opdateret 7. aug. 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- og 20 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06580314Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Seattle Children's Hospital, Seattle
RekruttererFase 2
Alder 1 til 26 · Alle køn · Opdateret 4. aug. 2026 · NCT07680439Resilience Mobile App for Teens and Young Adults With Cancer
- Seattle Children's Hospital, Seattle
Rekrutterer
Alder 12 til 25 · Alle køn · Opdateret 3. aug. 2026 · NCT05842902A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Swedish Cancer Institute, Edmonds
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. jul. 2026 · NCT05719558A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Fred Hutchinson Cancer Center. /ID# 267940, Seattle
- Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05650632Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Fred Hutchinson Cancer Research Center, Seattle
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 30. jun. 2026 · NCT06162221A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Seattle
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. jun. 2026 · NCT06431594Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT06993844Childhood Cancer Survivor Study
- Seattle Children's Hospital, Seattle
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Alle køn · Opdateret 17. jun. 2026 · NCT01120353Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 17. jun. 2026 · NCT05486572A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT06051695A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- University of Washington Medical Center /ID# 275866, Seattle
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 8. jun. 2026 · NCT07005102ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT03686124Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.